Quidel, a diagnostic testing solutions provider, has received CE mark approval for its Sofia strep A fluorescent immunoassay (FIA) test for use with its Sofia analyser.
The Sofia analyser and Sofia strep A FIA integrates lateral flow technology, fluorescent chemistry, failure alert and fail-safe systems to provide accurate diagnostic result.
Quidel president and CEO Douglas Bryant said in combination with their Sofia influenza A+B FIA, Sofia strep A FIA will provide healthcare providers with added testing versatility during this respiratory disease season.
Â
Â
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
![](/wp-content/themes/goodlife-wp-B2B/assets/images/company-profile-unit.png)
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData